BioSpace News Archive

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022.

Viveve Medical, Inc., a medical technology company focused on women’s health and the treatment of stress urinary incontinence, announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022.

The FDA accepted for review a Biologics License Application (BLA) from ImmunityBio, Inc. (NASDAQ: IBRX), for its antibody cytokine fusion protein as a treatment for patients with BCG-unresponsive non-muscle-invasive bladder cancer carcinoma in situ (CIS) with or without Ta or T1 disease.

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, reported net income of $64 million for the quarter ended June 30, 2022, a 15% increase over the prior year.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2022.

iPreg Incorporation, an award-winning biomedical device manufacturer in the field of reproductive medicine, has developed a new and enhanced solution for infertility.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Gaucher disease, also called lysosomal storage disorder, is an autosomal recessive metabolic disorder, with the possibility of affecting an estimate of 1 in 100,000 people.

Most drug addicts find it difficult to wean themselves away from the fatal substance and require a protracted therapy for that.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Fermentation is one of the most favored techniques for food protection inferable from the medical advantages presented by this process.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The rising awareness about prostate-related diseases among a considerable chunk of the global populace may prove to be a prime growth accelerator for the global benign prostatic hyperplasia therapeutics market during the forecast period of 2021-2031.